News | Owlpharma Consulting

GMDP, Legislation

Annex 1 - Manufacture of Sterile Medicinal Products

/

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

August 29, 2022

About

Drivers

Partnerships

Locations

Medical & Scientific

Quality Assurance

Regulatory Affairs

Pharmacovigilance

Audits

Join us

Training & Events

Industry's latest updates

+351 239 781 014

Chamada para rede nacional

owlpharma@owlpharma.com

No spam. Notifications onlyaboutnew products andupdates. You can alwaysunsubscribe.

No spam. Notifications onlyaboutnew products andupdates. You can alwaysunsubscribe.

Subscribe Newsletter

Contratos em Farmacovigilância

Contratos em Farmacovigilância

Publicidade de Produtos de Saúde - DMs, Cosméticos e Suplementos Alimentares

Publicidade de Produtos de Saúde - DMs, Cosméticos e Suplementos Alimentares

The Updated GACP Guideline: What's new? Connecting the Dots Between Farming and Pharma

New Requirements for EudraVigilance Signal Monitoring under Implementing Regulation (EU) 2025/1466

Medical & Scientific

Quality Assurance

Pharmacovigilance

Audits

More

The Updated GACP Guideline: What's new? Connecting the Dots Between Farming and Pharma

Heading

The Updated GACP Guideline: What's new? Connecting the Dots Between Farming and Pharma

New Requirements for EudraVigilance Signal Monitoring under Implementing Regulation (EU) 2025/1466

Major Overhaul of EU Pharmacovigilance Rules: Key Changes Introduced by Implementing Regulation (EU) 2025/1466

EMA Strengthens Data Protection Measures in ICSRs

Planning to Export or Import Medicinal Cannabis? Get Ready for INFARMED’s New Requirements

EMA’s expectations on the use of third-party GMP audit reports

New MDCG Guidance: Clinical evaluation of orphan medical devices

SCCS - Scientific Advice on Titanium dioxide (TiO2)

New MDCG guidance: Investigator’s Brochure and Summary of Safety and Performance Template

Environmental Risk Assessment - The long-awaited updated guideline

New HMA-EMA catalogues of real-world data sources and studies

The Updated GACP Guideline: What's new? Connecting the Dots Between Farming and Pharma

Planning to Export or Import Medicinal Cannabis? Get Ready for INFARMED’s New Requirements

European Shortages Monitoring Platform (ESMP) Goes Live

New National Regulations on Medicines Export and Availability

Annual Price Revision for 2025

New European Health Technology Assessment Framework for 2025

New Requirements for EudraVigilance Signal Monitoring under Implementing Regulation (EU) 2025/1466

Major Overhaul of EU Pharmacovigilance Rules: Key Changes Introduced by Implementing Regulation (EU) 2025/1466

EMA Strengthens Data Protection Measures in ICSRs

Risk Minimisation Measures - GVP Latest Updates

World Patient Safety Day

Desafios atuais de Farmacovigilância - Edição 2024

EMA’s expectations on the use of third-party GMP audit reports

European Shortages Monitoring Platform (ESMP) Goes Live

The legal framework of medicinal cannabis in Portugal

Handling API manufacturers: Insights from the New CEFIC-APIC Guide and Owlpharma recent experience

Owlpharma becomes a member of the 3PARL

GCP Audits - A new piece in our compliance puzzle

Owlpharma's Quality Management System - Certification ISO 9001:2015

Inauguração da nova sede

Desafios atuais de Farmacovigilância - Edição 2024

Fórum de Diretores Técnicos de Distribuição

New HMA-EMA catalogues of real-world data sources and studies

Owlpharma becomes a member of the 3PARL

The Updated GACP Guideline: What's new? Connecting the Dots Between Farming and Pharma

New Requirements for EudraVigilance Signal Monitoring under Implementing Regulation (EU) 2025/1466

Major Overhaul of EU Pharmacovigilance Rules: Key Changes Introduced by Implementing Regulation (EU) 2025/1466

EMA Strengthens Data Protection Measures in ICSRs

Planning to Export or Import Medicinal Cannabis? Get Ready for INFARMED’s New Requirements

European Shortages Monitoring Platform (ESMP) Goes Live

The Updated GACP Guideline: What's new? Connecting the Dots Between Farming and Pharma

New Requirements for EudraVigilance Signal Monitoring under Implementing Regulation (EU) 2025/1466

Major Overhaul of EU Pharmacovigilance Rules: Key Changes Introduced by Implementing Regulation (EU) 2025/1466

EMA Strengthens Data Protection Measures in ICSRs

Planning to Export or Import Medicinal Cannabis? Get Ready for INFARMED’s New Requirements

EMA’s expectations on the use of third-party GMP audit reports

Annex 1 - Manufacture of Sterile Medicinal Products

PME Excelência '21

No spam. Notifications only
aboutnew products and
updates. You can always
unsubscribe.

No spam. Notifications only
aboutnew products and
updates. You can always
unsubscribe.